Search the Newsreel

Should I buy Agencia Comercial Spirits Ltd (AGCC)

Ultragenyx Pharmaceutical Inc. Revenue Breakdown – NASDAQ:RARE

This article provides a breakdown of Ultragenyx Pharmaceutical Inc.'s (NASDAQ: RARE) revenue. Last year, the company generated $673.00 million USD, with its Novel Products segment being the top contributor at $673.00 million USD. Geographically, North America was the largest contributor, accounting for $377.00 million …

Blackstone Mortgage Trust director Nassau buys $143,357 in stock

Henry N Nassau, a director at Blackstone Mortgage Trust, Inc. (NYSE:BXMT), purchased 10,000 shares of the company’s Class A Common Stock for $143,357. This transaction occurred on August 4, 2026, as the stock traded near its 52-week low. The company recently reported mixed Q2 …

Ares Management (ARES) Just Moved, What Is Drawing Attention Now?

Legal & General shares have a dividend yield of 7.1%. What’s the catch?

Illinois puts 60 community solar arrays atop self-storage roofs, preserving farmland, lowering bills

Illinois is implementing an innovative approach to community solar by installing 60 solar arrays on the roofs of self-storage facilities, aiming to preserve farmland and reduce electricity bills. This strategy leverages often-overlooked commercial roof space, with 10 arrays already operational and a projected capacity …

Abacus (ABX) Q2 2026 Earnings Call Transcript

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope

Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …

Dollar General (DG), What Is Drawing Fresh Attention Now?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Dollar General (DG) is back on investors' radar after a recent share price move, with the stock closing at US$123.28. That change, alongside mixed short term returns, …

MacroGenics (MGNX) Stock Faces A Revenue Reality Check After Deeper Losses

ETFs Investing in Meritage Homes Corporation Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Meritage Homes Corporation (MTH) stocks. It provides a detailed table including the market value, weight, issuer, management style, focus, expense ratio, AUM, price, change percentage, relative volume, and 3-year NAV total return for each …

Page Industries Limited (NSE:PAGEIND) Stock Goes Ex-Dividend In Just Two Days

QIAGEN NV Revenue Breakdown – TRADEGATE:QIA

QIAGEN NV (TRADEGATE:QIA) reported a total revenue of €1.78 billion last year. The Diagnostic Solutions segment was the top performer, generating €683.76 million, although this was a decrease from the previous year's €723.42 million. The United States was the largest geographical contributor, accounting for …

Seritage Growth Properties (SRG) Stock Faces Shrinking Revenue Despite Narrower Losses

HGBL: Profitable Mix Reset And Loan Synergies Will Drive Future Repricing

Analysts have revised their 12-month price target for Heritage Global (HGBL) to $3.00 from $4.50, driven by an expected reset towards a more profitable business mix and potential synergies in commercial loans. The company's fair value has been decreased by 17% to $2.83, despite …

Top Generate Biomedicines (GENB) Competitors 2026

Usiminas (BOVESPA:USIM5) Stock Fair Value Moves Lower As Analysts Split On Steel Outlook

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The updated fair value price target for Usinas Siderúrgicas de Minas Gerais has shifted from R$9.59 to about R$8.87, which sits between the …

PepGen’s DM1 Bet Runs Into An FDA Hold And Dilution Fears

PepGen (PEPG) is a clinical-stage biotech focused on its lead program PGN-EDODM1 for myotonic dystrophy type 1 (DM1). The company's stock performance is highly volatile and tied to clinical progress, regulatory outcomes, and financing events, including a recent FDA partial clinical hold and an …

Is Genius Sports (GENI) Undervalued After Raising 2026 Revenue Guidance?

Genius Sports (GENI) has raised its full-year 2026 revenue outlook after reporting strong Q2 and H1 2026 results. Despite a year-to-date share price decline, the stock has shown significant short-term momentum, partly due to new data partnerships. While the company is considered undervalued by …

Genesis Energy (GEL) On Fresh Earnings And Buyback Progress Still Looks Hard To Value

Genesis Energy (GEL) has reported its second-quarter 2026 results and completed a share buyback tranche, prompting a re-evaluation of the midstream partnership. Despite recent share price momentum, its 78.1x P/E ratio is significantly higher than sector averages, indicating potential overvaluation, especially given declining revenue …

Technical Reactions to NGNE Trends in Macro Strategies

This article analyzes Neoleukin Therapeutics Inc. (NASDAQ: NGNE) using AI models to develop distinct trading strategies. It highlights a strong near-term sentiment potentially leading to a long-term positive bias, with an exceptional risk-reward short setup. The analysis provides specific entry, target, and stop-loss levels …

Genco Shipping & Trading (GNK) Faces A Valuation Test, Is The Remaining Upside Enough?

Lang & Schwarz Aktie: 36 Prozent Erholung seit Juli-Tief

Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts

Ocugen is aiming for 2027 Biologics License Application (BLA) filings for its OCU400 retinitis pigmentosa and OCU410ST Stargardt disease gene therapies, with potential launches in 2028. The company expects key clinical readouts next year, including Phase III OCU400 data in Q1 and Phase II/III …

The Army gave General Dynamics $533M to build an artillery plant that produced nothing

The U.S. Army spent $533 million on a General Dynamics artillery plant in Mesquite, Texas, intended to produce shells for Ukraine, but the facility never yielded a single usable shell. Despite promises of innovative Turkish-made robots, the plant was plagued by repeated failures, including …

ETFs Investing in Bunge Global SA Stocks

This article lists various ETFs that include Bunge Global SA (BG) stocks in their portfolios. The ETFs are sorted by market value and provide details such as issuer, management style, expense ratio, assets under management (AUM), and 3-year NAV total return, offering insights for …

Why Cogent Biosciences (COGT) Is Down 10.5% After Reporting Wider First-Half 2026 Losses – And What's Next

First Advantage (FA) Could Be 14% Overvalued Following Strong Results And Higher Guidance

Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?

Lineage, Inc. reported widening net losses of US$29 million in Q2 2026 and US$75 million for the half-year, despite a slight increase in sales. This raises concerns about rising costs and margin pressures, prompting investors to scrutinize the company's financial health. The article suggests …

ETFs Investing in Prestige Consumer Healthcare Inc Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold stocks of Prestige Consumer Healthcare Inc. The list, sorted by market value, includes various ETFs with details such as issuer, management style, focus, expense ratio, assets under management (AUM), price, change, …

CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit Against Pentwater Capital Management LP

The Rosen Law Firm announces a class action lawsuit opportunity for purchasers of Avis Budget Group, Inc. (NASDAQ: CAR) securities against Pentwater Capital Management LP. The lawsuit alleges that Pentwater Capital Management LP and its CEO manipulated Avis's market, triggering unusual volatility and a …

Directivo de Avis Budget Group vende 652.574 dólares en acciones

Avis Budget Group EVP sells $652,574 in company stock

Ravi Simhambhatla, EVP and Chief Digital & Innovation Officer at Avis Budget Group (NASDAQ:CAR), sold common stock totaling $652,574 in multiple transactions on August 7, 2026. Following the sales, Mr. Simhambhatla directly owns 18,810 shares. This transaction comes as InvestingPro analysis suggests the stock …

Is General Mills (GIS) Reasonable for Value Investors Today?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. General Mills stock has had a weak run over the past few years, while current valuation checks suggest the shares are neither a clear bargain nor obviously …

Brookfield (TSX:BN) Deepens Its Reach In Insurance And AI Infrastructure

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Brookfield Corporation (TSX:BN) expands its global insurance footprint through recently completed acquisitions that add …

Is Stronger Earnings and Dividend Growth Altering The Investment Case For MGE Energy (MGEE)?